Chief Executive Officer
Current
Sep 2020 - Present
AeroLeads people directory · profile
Daniel Elger Email & Phone Number
CEO at CABI
at
CABI
1 work email found
@cabi.org
2 phones found area 617
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Who is Daniel Elger? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Daniel Elger is listed as CEO at CABI at CABI, based in Greater Oxford Area, United Kingdom. AeroLeads shows a work email signal at cabi.org, phone signal with area code 617, and a matched LinkedIn profile for Daniel Elger.
Daniel Elger previously worked as Chief Executive Officer at Cabi and Non Executive Director at Conidia Bioscience. Daniel Elger holds Phd, Cancer Biology from University Of Oxford.
Company email context
Email format at CABI
This section adds company-level context without repeating Daniel Elger's masked contact details.
delger@cabi.org
76% confidence
AeroLeads found 1 current-domain work email signal for Daniel Elger. Compare company email patterns before reaching out.
Profile bio
About Daniel Elger
Appointed as CEO of international development and knowledge organisation CABI in 2020 following 25 years of experience in life sciences, including 13 years at senior management/board level in medical biotech, mainly in public companies. Extensive leadership, R&D, strategic, commercial, financial, fundraising, investor/stakeholder relations, marketing and communications experience. History of work across drug product lifecycle from discovery to patent expiry. Experience working with larger pharma companies through agency career, BD/transactional work and biotech-pharma collaborations. Strong medical science background.
Listed skills include Pharmaceutical Industry, Biotechnology, Biopharmaceuticals, Clinical Development, and 11 others.
Current workplace
Daniel Elger's current company
Company context helps verify the profile and gives searchers a useful next step.
9 roles
Daniel Elger work experience
A career timeline built from the work history available for this profile.
Non Executive Director
Current
Dec 2020 - Present
Senior Vice President R&D And Chief Commercial Officer
NASDAQ and AIM-listed company focused on the developement of novel anti-infectives. Responsible for commercial, medical affairs and business development functions. Member of Company’s Executive Committee (along with CEO and COO). Led the establishment of a commercial footprint in the US for the planned launch of the Company’s Phase 3 anti-infective product, ridinilazole, as well as the negotiation and execution of the 2017 acquisition of Discuva, which provided Summit with a platform for discovery of novel antibacterial drugs.
Jun 2015 - May 2020
Chief Financial & Corporate Development Officer
Pioneer in the NOX field, which during my tenure had a lead drug in phase 2 for diabetic nephropathy.Role spanned pipeline development planning, financing, preparation for potential public listings, corporate development and external relations. Member of senior leadership team.
Jun 2014 - Apr 2015
Chief Financial Officer
AIM-listed biotech with network pharmacology drug discovery platform; during my tenure the company had drugs in clinical development for cancer and depression.Board member and Executive Director. Led a £40m fundraising on AIM. Responsible for finance department and operations and external communications.
Jun 2011 - Apr 2014
Vp, Marketing & Communications
Member of Senior Management Team.Antisoma was an oncology-focused biotech company listed on the LSE; the company developed drugs from preclinical or early clinical evaluation through to partnering deals, pivotal studies or approval in settings including lung cancer, prostate cancer, breast cancer, ovarian cancer, AML, CLL and renal cancer.
May 2002 - Mar 2011
Programme Director
(Avenue HKM, later acquired by Huntsworth; formerly Blackwell Healthcare)Specialised healthcare marketing and PR agency servicing the pharmaceutical industry
Sep 1997 - May 2002
Development Editor
Mosby-Wolfe
Scientific, technical and medical publishing company
Sep 1996 - Sep 1997
Managing Editor/Senior Editor
Scientific, technical and medical publishing company
Sep 1994 - Sep 1996
3 education records
Daniel Elger education
Phd, Cancer Biology
University Of Oxford
Ba, Medicine (Physiological Sciences)
University Of Oxford
Education record
Whitley Abbey Comprehensive School, Coventry
FAQ
Frequently asked questions about Daniel Elger
Quick answers generated from the profile data available on this page.
What company does Daniel Elger work for?
Daniel Elger works for CABI.
What is Daniel Elger's role at CABI?
Daniel Elger is listed as CEO at CABI at CABI.
What is Daniel Elger's email address?
AeroLeads has found 1 work email signal at @cabi.org for Daniel Elger at CABI.
What is Daniel Elger's phone number?
AeroLeads has found 2 phone signal(s) with area code 617 for Daniel Elger at CABI.
Where is Daniel Elger based?
Daniel Elger is based in Greater Oxford Area, United Kingdom while working with CABI.
What companies has Daniel Elger worked for?
Daniel Elger has worked for Cabi, Conidia Bioscience, Summit Therapeutics, Genkyotex S.A, and E-Therapeutics Plc.
How can I contact Daniel Elger?
You can use AeroLeads to view verified contact signals for Daniel Elger at CABI, including work email, phone, and LinkedIn data when available.
What schools did Daniel Elger attend?
Daniel Elger holds Phd, Cancer Biology from University Of Oxford.
What skills is Daniel Elger known for?
Daniel Elger is listed with skills including Pharmaceutical Industry, Biotechnology, Biopharmaceuticals, Clinical Development, Lifesciences, Oncology, Drug Discovery, and Drug Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial